BETTA PHARMACEUTICALS CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07D HETEROCYCLIC COMPOUNDS 9153
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 7248
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07K PEPTIDES 2134
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C30B SINGLE-CRYSTAL GROWTH 155

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0235,757 ICOTINIB-CONTAINING TOPICAL SKIN PHARMACEUTICAL COMPOSITIONS AND USES THEREOFOct 11, 14Aug 18, 16[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9783524 Protein tyrosine kinase modulators and methods of useJul 11, 14Oct 10, 17[C07D]
9688687 Polymorphic forms of icotinib phosphate and uses thereofJun 09, 14Jun 27, 17[A61K, C07D, C30B]
9617257 Fused pyridine derivatives useful as c-Met tyrosine kinase inhibitorsJul 01, 13Apr 11, 17[C07D]
9611272 Polymorphic forms of icotinib and uses thereofJun 09, 14Apr 04, 17[A61K, C07D]
9505774 Polymorphic forms of icotinib maleate and uses thereofJun 09, 14Nov 29, 16[A61K, C07D, C07C]
9487570 Glucagon like peptide analogs, composition, and method of useMay 17, 10Nov 08, 16[A61K, A61P, C07K]
9409900 Compound for increasing kinase active and application thereofNov 09, 11Aug 09, 16[C07D]
9242991 Substituted fused heterocycles as c-Met tyrosine kinase inhibitorsJul 14, 11Jan 26, 16[A61K, C07D]
9085588 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereofDec 28, 12Jul 21, 15[C07D]
8951959 Glucagon-like peptide-1 analogues and uses thereofApr 29, 11Feb 10, 15[A61K, A61P, C07K]

Expired/Abandoned/Withdrawn Patents

  • No Patents to Display

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.